Enhancing Fear Extinction Via Angiotensin Type 1 Receptor Inhibition: A Randomized Controlled Trial in Posttraumatic Stress Disorder
Phase of Trial: Phase III
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Losartan (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- Acronyms LOSe-PTSD
- 30 Jul 2016 Status changed from not yet recruiting to recruiting.
- 19 May 2016 Planned initiation date changed from 1 May 2016 to 1 Jun 2016.
- 18 Mar 2016 New trial record